Participation in the World's Largest International Aesthetic Medicine Congress

Samyang Biopharm announced on February 2 that it held a symposium on the latest procedures using its biostimulator "Lafullen" and lifting thread "Croquis" at the International Master Course on Aging Science (IMCAS) World Congress 2026, which took place in Paris, France, for three days from January 29 to 31.


Since 2020, Samyang Biopharm has participated in IMCAS every year, operating a promotional booth and hosting symposiums to share the latest procedural techniques and clinical cases for each product, with the aim of promoting the excellence of its self-developed aesthetic medical products and expanding its overseas markets. This year’s symposium, in particular, focused on showcasing procedures using Lafullen, with over 150 global medical professionals in attendance.

Director Kyungkuk Hong is introducing the Rapullen procedure at the International Master Course on Aging Science (IMCAS) World Congress 2026. Samyang Biopharm

Director Kyungkuk Hong is introducing the Rapullen procedure at the International Master Course on Aging Science (IMCAS) World Congress 2026. Samyang Biopharm

View original image

Lafullen, launched in 2022, is primarily composed of PCL (Polycaprolactone), a biodegradable medical polymer. It functions as a filler to create natural volume and also acts as a biostimulator that induces collagen production. Biostimulators, which have recently gained significant attention in the field of aesthetic medicine, are products that not only enhance facial volume but also help the skin regenerate itself.


At this symposium, Director Kyungkuk Hong of Clinique Who's Who, Director Kiwoong Hong of Sam Skin Plastic Surgery, and Dr. Clara Santos, a dermatologist from Brazil, participated as speakers. They shared procedural strategies and clinical cases under the theme "Facial and Body Rejuvenation and Contouring with LAFULLEN PCL Biostimulator and Croquis PDO Threads."


In the presentation on Lafullen, the speakers introduced the product’s characteristics and demonstrated Lafullen procedures based on functional anatomy. In particular, they shared various techniques, including "Ligamentous Lifting," which reinforces the ligaments that maintain facial structure to help define facial lines; "Skin Tightening," which enhances elasticity by inducing collagen regeneration; and "SMAS Contouring," which contracts and rearranges the SMAS (Superficial Musculoaponeurotic System) layer located between the subcutaneous fat and muscle layers to refine facial contours.


Dr. Clara Santos then presented facial and body contouring procedures and clinical cases using Croquis, a PDO (Polydioxanone)-based lifting thread that naturally degrades in the body over time. Developed using Samyang Biopharm’s biodegradable suture yarn technology, Croquis received European CE certification in the year of its launch in 2019, demonstrating its technological excellence and safety.



Kim Kyungjin, CEO of Samyang Biopharm, stated, "Through this symposium, we effectively communicated the product performance and clinical value of Lafullen and Croquis to global medical professionals," adding, "We will continue to strengthen our presence in the global aesthetic medicine market based on our differentiated technological capabilities."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing